Login / Signup

Incidence of Pneumocystis jirovecii pneumonia utilizing a polymerase chain reaction-based diagnosis in patients receiving bendamustine.

Mikhaila L RiceJason N BarretoCarrie A ThompsonKristin C ColePritish K ToshAndrew H Limper
Published in: Cancer medicine (2021)
Our incidence of PJP below 3.5%, the conventional threshold for prophylaxis implementation, indicates routine anti-Pneumocystis prophylaxis may not be necessary in this population. Factors indicating a high-risk population for targeted prophylaxis require further investigation.
Keyphrases
  • risk factors
  • healthcare
  • clinical practice
  • cancer therapy
  • quality improvement
  • intensive care unit